Chambers Review
Provided by Chambers
Chambers Guide to the USA
Life Sciences: Corporate/Commercial - USA - Nationwide
Individual Editorial
Mitchell Bloom is global chair of Goodwin’s life sciences practice. He advises emerging innovator companies, investment banks and venture capital firms worldwide on capital markets offerings, M&A and venture capital transactions.
Capital Markets - Massachusetts
Individual Editorial
Mitchell Bloom is a highly experienced capital markets practitioner and regularly handles IPOs for clients in the biotechnology sector.
Life Sciences - Massachusetts
Individual Editorial
Mitchell Bloom co-chairs the firm's global life sciences group and is frequently called upon by emerging and established life sciences companies for counseling on a range of matters, including M&A, IPOs and financings.
Corporate/M&A - Massachusetts
Individual Editorial
Mitchell Bloom offers broad expertise in transactional and securities work, notably for clients in the life sciences sector. Clients turn to him for his advice across the company lifecycle, with startups, emerging businesses and mature companies calling upon his skills in financings, capital markets work and M&A.
Startups & Emerging Companies - USA - Nationwide
Individual Editorial
Mitchell Bloom draws acclaim for his representation of startups in the life science sector. He has particular experience in transactions involving emerging biotechnology companies.
Capital Markets: Debt & Equity: Eastern United States - USA - Nationwide
Individual Editorial
Mitchell Bloom focuses his capital markets practice on the life sciences sector and he possesses a particular aptitude for IPOs.